China vs Singapore: Immunization, HepB3
China
96.0%
in 2024
Singapore
96.0%
in 2024
China rank
42nd
Singapore rank
42nd
Immunization, HepB3 over time
- China
- Singapore
How they compare
China currently reports 96.0% against 96.0% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Singapore ahead.
China ranks 42nd and Singapore ranks 42nd of 188 countries.
Across the 3 decades both report, China averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | China | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.0% | 95.6% | 14.6% | Singapore |
| 2010s | 99.0% | 96.4% | 2.6% | China |
| 2020s | 97.8% | 96.6% | 1.2% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, China or Singapore?
- China, at 96.0% against 96.0% in Singapore as of 2024.
- What is the difference in immunization, hepb3 between China and Singapore?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Singapore?
- 25 years are reported by both, from 2000 to 2024.
- How do China and Singapore rank globally for immunization, hepb3?
- China ranks 42nd and Singapore ranks 42nd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.